Next Article in Journal
Preparation of Puerarin Chitosan Oral Nanoparticles by Ionic Gelation Method and Its Related Kinetics
Next Article in Special Issue
MHC Class I Stability is Modulated by Cell Surface Sialylation in Human Dendritic Cells
Previous Article in Journal
Crystallisation Behaviour of Pharmaceutical Compounds Confined within Mesoporous Silicon
Previous Article in Special Issue
Blood Eosinophilia Is an on-Treatment Biomarker in Patients with Solid Tumors Undergoing Dendritic Cell Vaccination with Autologous Tumor-RNA
 
 
Article
Peer-Review Record

PGE2 Is Crucial for the Generation of FAST Whole- Tumor-Antigens Loaded Dendritic Cells Suitable for Immunotherapy in Glioblastoma

Pharmaceutics 2020, 12(3), 215; https://doi.org/10.3390/pharmaceutics12030215
by Sara Nava 1,*, Daniela Lisini 1, Simona Frigerio 1, Simona Pogliani 1, Serena Pellegatta 2,3, Laura Gatti 1, Gaetano Finocchiaro 2, Anna Bersano 1 and Eugenio Agostino Parati 1
Reviewer 2: Anonymous
Pharmaceutics 2020, 12(3), 215; https://doi.org/10.3390/pharmaceutics12030215
Submission received: 4 February 2020 / Revised: 25 February 2020 / Accepted: 25 February 2020 / Published: 2 March 2020
(This article belongs to the Special Issue Dendritic Cell Vaccines)

Round 1

Reviewer 1 Report

This study is of high significance, well-designed and presented.

In the Introduction, the authors mention "several groups have shown that it is possible to obtain mature DC in 2–3 days cell culture [13-17]". In their study, the authors present one more fast DC method. However, it is not clear from the manuscript why the scientific community should to have one more fast method to obtain mature DC. The authors should compare in detail their method with previously published fast DC protocols and explain possible advantages and drawbaks. This comparison could be presented as an additional Figure/table/scheme.

Author Response

We thank the Reviewer for the generous comments. We have edited the manuscript to address his concern. The Reviewer can find the modification on the discussion paragraph (yellow underlined). Please see the attachment for Table S1 and revised manuscript.

Best regards

Sara Nava

Author Response File: Author Response.docx

Reviewer 2 Report

Nava Et al. reported a fast protocol for the production of DC loaded with whole tumor lysate, which could be potentially translated to a GMP-compatible platform. The manuscript is well written, the topic was clearly explained and put into context. Experimental strategy and results were clearly described and well presented in a logical order.

Author Response

We thank the Reviewer for the generous comments.

Please see the attachment for revised manuscript. The Reviewer can find the modification on the discussion paragraph (yellow underlined).

Best regards

Sara Nava

Author Response File: Author Response.docx

Back to TopTop